Eli Lilly & Co. (LLY)

• Annual Data
• Quarterly Data

Eli Lilly & Co., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders’ Equity

		Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Short-term borrowings and current maturities of long-term debt
	Accounts payable
	Employee compensation
	Sales rebates and discounts
	Dividends payable
	Income taxes payable
	Deferred income taxes
	Other current liabilities
	Current liabilities
	Long-term debt, excluding current maturities
	Accrued retirement benefits
	Long-term income taxes payable
	Other noncurrent liabilities
	Other liabilities
	Total liabilities
	Common stock, no par value
	Additional paid-in capital
	Retained earnings
	Employee benefit trust
	Accumulated other comprehensive loss
	Cost of common stock in treasury
	Total Eli Lilly and Company shareholders’ equity
	Noncontrolling interests
	Total equity
	Total liabilities and equity

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).